Literature DB >> 28130616

Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.

V K Kimiskidis1, Vasileios Papaliagkas2, S Papagiannopoulos3, D Zafeiriou4, D Kazis3, E Tsatsali-Foroglou5, Z Kouvatsou3, V Kapina3, D Koutsonikolas6, G Anogianakis6, T Geroukis7, S Bostantjopoulou3.   

Abstract

Canavan's disease (CD) is a hereditary leukodystrophy caused by mutations in the aspartoacylase gene (ASPA), leading to spongiform degeneration of the white matter and severe impairment of psychomotor development. We present the cases of two non-Jewish sisters with CD that have a milder and protracted clinical course compared to typical CD. MRI imaging revealed bilateral high-signal-intensity areas in the thalami and the internal capsule and MR spectroscopy showed typical findings for CD (a marked increase in N-acetylaspartate (NAA) levels). FA values of the right and left corticospinal tracts at the level of the posterior limb of the internal capsule, and the centrum semiovale were found to be significantly reduced compared to healthy controls. From a neurophysiological point of view, the peripheral motor system was normal. In contrast, cortical stimulation at maximal intensity failed to elicit facilitated or resting MEPs and silent periods (SPs) in upper and lower limbs, providing evidence for significant upper motor pathway dysfunction.

Entities:  

Keywords:  Canavan’s disease; DTI; TMS

Mesh:

Substances:

Year:  2017        PMID: 28130616     DOI: 10.1007/s11011-017-9955-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  17 in total

Review 1.  Diffusion tensor imaging: a review for pediatric researchers and clinicians.

Authors:  Heidi M Feldman; Jason D Yeatman; Eliana S Lee; Laura H F Barde; Shayna Gaman-Bean
Journal:  J Dev Behav Pediatr       Date:  2010-05       Impact factor: 2.225

2.  Radiological clue to diagnosis of Canavan disease.

Authors:  Priya Sreenivasan; K K Purushothaman
Journal:  Indian J Pediatr       Date:  2012-06-02       Impact factor: 1.967

3.  Multimodal evoked potential studies in leukodystrophies of children.

Authors:  L J De Meirleir; M J Taylor; W J Logan
Journal:  Can J Neurol Sci       Date:  1988-02       Impact factor: 2.104

4.  Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.

Authors:  R Matalon; K Michals; D Sebesta; M Deanching; P Gashkoff; J Casanova
Journal:  Am J Med Genet       Date:  1988-02

5.  An atypical case of Canavan disease with stroke-like presentation.

Authors:  Katherine E Delaney; Stephen F Kralik; Bryan E Hainline; Meredith R Golomb
Journal:  Pediatr Neurol       Date:  2014-10-25       Impact factor: 3.372

Review 6.  Canavan disease: clinical features and recent advances in research.

Authors:  Hideki Hoshino; Masaya Kubota
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

7.  Atypical clinical and radiological course of a patient with Canavan disease.

Authors:  Catherine Sarret; Odile Boespflug-Tanguy; Diana Rodriguez
Journal:  Metab Brain Dis       Date:  2015-11-19       Impact factor: 3.584

8.  The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibe Nejad Biglari; Elham Rahimian; Farzad Ahmadabadi; Hamid Nemati; Mohamad Mehdi Nasehi; Mohammad Ghofrani; Mohsen Mollamohammadi
Journal:  Iran J Child Neurol       Date:  2014

9.  A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination.

Authors:  Marina R Carpinelli; Anne K Voss; Michael G Manning; Ashwyn A Perera; Anne A Cooray; Benjamin T Kile; Rachel A Burt
Journal:  Dis Model Mech       Date:  2014-03-28       Impact factor: 5.758

10.  Loss of central auditory processing in a mouse model of Canavan disease.

Authors:  Georg von Jonquieres; Kristina E Froud; Claudia B Klugmann; Ann C Y Wong; Gary D Housley; Matthias Klugmann
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.